Rights and permissions
About this article
Cite this article
IM long-acting octreotide beneficial in malignant carcinoid syndrome. Inpharma Wkly. 1379, 14 (2003). https://doi.org/10.2165/00128413-200313790-00028
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200313790-00028